High Expression of the Very Late Antigen (VLA)-4 (CD49d) Integrin Predicts for Reduced Risk of Relapse and Better Outcome in Pediatric Acute Myeloid Leukemia (AML): A Report From the Children's Oncology Group.

Walter, W. B., Alonzo, T. A., Gerbing, R. B., Smith, F. O., Raimondi, S. C., Hirsch, B. A., … Meshinchi, S. (2009). High Expression of the Very Late Antigen (VLA)-4 (CD49d) Integrin Predicts for Reduced Risk of Relapse and Better Outcome in Pediatric Acute Myeloid Leukemia (AML): A Report From the Children’s Oncology Group. Blood, 114(22), 1592–1592. https://doi.org/10.1182/blood.v114.22.1592.1592